BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

News: BNO Bionomics Initiates Phase 2 Study Of BNC210 For Acute Treatment Of Social Anxiety Disorder

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    03/01/22
    22:20
    Post #: 58617971

    Jan 3 (Reuters) - Bionomics Ltd (BNO) :

    • BIONOMICS INITIATES PHASE 2 PREVAIL STUDY OF BNC210 FOR ACUTE TREATMENT OF SOCIAL ANXIETY DISORDER
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
NEWS Arrowsmith North Silica Sand Project granted works approval
right-arrow Created with Sketch.
BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
NEWS Final toll milling completed at Jeffreys Find Gold Mine
right-arrow Created with Sketch.
NEWS Rubix advances proposed acquisition of prospective Bauxite Projects in Africa
right-arrow Created with Sketch.
NEWS Stay ahead - view the latest ASX market news
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.